We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

120 hedge funds and large institutions have $657M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 22

0.14% more ownership

Funds ownership: 21.79%21.93% (+0.14%)

9% less funds holding

Funds holding: 132120 (-12)

36% less call options, than puts

Call options by funds: $3.45M | Put options by funds: $5.36M

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

40% less funds holding in top 10

Funds holding in top 10: 106 (-4)

64% less capital invested

Capital invested by funds: $1.83B → $657M (-$1.17B)

Holders
120
Holders Change
-12
Holders Change %
-9.09%
% of All Funds
1.89%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.09%
New
17
Increased
58
Reduced
22
Closed
28
Calls
$3.45M
Puts
$5.36M
Net Calls
-$1.91M
Net Calls Change
-$2.33M
Name Holding Trade Value Shares
Change
Change in
Stake
WBC
51
Westpac Banking Corp
Australia
$1.71M +$60.5K +2,360 +2%
Qube Research & Technologies (QRT)
52
Qube Research & Technologies (QRT)
United Kingdom
$1.66M +$757K +29,532 +40%
UBS Group
53
UBS Group
Switzerland
$1.66M +$809K +31,577 +45%
Swiss National Bank
54
Swiss National Bank
Switzerland
$1.64M +$415K +16,200 +19%
Northern Trust
55
Northern Trust
Illinois
$1.42M +$79.8K +3,113 +4%
Sumitomo Mitsui Trust Group
56
Sumitomo Mitsui Trust Group
Japan
$1.38M +$143K +5,578 +7%
D.E. Shaw & Co
57
D.E. Shaw & Co
New York
$1.33M +$433K +16,914 +26%
CS
58
Credit Suisse
Switzerland
$1.29M +$133K +5,198 +7%
JAM
59
Jupiter Asset Management
United Kingdom
$1.23M +$1.55M +60,625 +410%
Schroder Investment Management Group
60
Schroder Investment Management Group
United Kingdom
$1.16M +$426K +16,617 +37%
Invesco
61
Invesco
Georgia
$1.1M +$662K +25,829 +62%
Citigroup
62
Citigroup
New York
$1.08M +$1.13M +44,264 +200%
PPA
63
Parametric Portfolio Associates
Washington
$993K +$932K +36,385 +147%
Mirae Asset Global Investments
64
Mirae Asset Global Investments
South Korea
$949K -$63.7K -2,484 -4%
N
65
Nuveen
North Carolina
$942K -$374K -14,600 -20%
Korea Investment Corp
66
Korea Investment Corp
South Korea
$882K +$571K +22,300 +70%
GAMH
67
Greenwoods Asset Management (HK)
Hong Kong
$880K +$1.39M +54,206 New
California Public Employees Retirement System
68
California Public Employees Retirement System
California
$861K -$2.56M -99,887 -65%
Bank of New York Mellon
69
Bank of New York Mellon
New York
$829K -$469K -18,316 -26%
SG Americas Securities
70
SG Americas Securities
New York
$705K -$3.35M -130,826 -75%
Charles Schwab
71
Charles Schwab
California
$548K +$35.1K +1,370 +4%
Wellington Management Group
72
Wellington Management Group
Massachusetts
$548K +$864K +33,718 New
Los Angeles Capital Management
73
Los Angeles Capital Management
California
$505K -$156K -6,099 -16%
CM
74
Caption Management
Oklahoma
$488K +$769K +30,000 New
VIA
75
Vident Investment Advisory
Georgia
$464K +$169K +6,608 +30%

NBP Hedge Fund Activity: Q1 2022 in Review

120 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2022, worth a combined $657M — down 64% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NBP and 17 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 58 added.

The largest buyer was Artisan Partners, adding an estimated $26M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.1M.

  • 120 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2022, down from 132 in Q4 2021.
  • Funds reported $657M of NovaBridge Biosciences American Depositary Shares stock for Q1 2022, down 64% quarter-over-quarter.
  • 17 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2022 and 28 closed out, a net change of -11 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2022 was Artisan Partners, an estimated $26M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2022 was T. Rowe Price Associates, an estimated $50.1M sold.

Based on aggregated 13F filings for Q1 2022.